Vimarsana
Biggest News Aggregation in the World

Office For Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Office For Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Office For Data Today - Breaking & Trending Today

Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England - Vimarsana News

Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England

Objective To explore how the number and type of breast cancers developed after screen detected atypia compare with the anticipated 11.3 cancers detected per 1000 women screened within one three year screening round in the United Kingdom. Design Observational analysis of the Sloane atypia prospective cohort in England. Setting Atypia diagnoses through the English NHS breast screening programme reported to the Sloane cohort study. This cohort is linked to the English Cancer Registry and the Mortality and Birth Information System for information on subsequent breast cancer and mortality. Particip...

Source: bmj.com
North Carolina data report shows decrease in dropouts, increase in school incidents - Vimarsana News

North Carolina data report shows decrease in dropouts, increase in school incidents

North Carolina public school units (PSUs) reported a decrease in dropouts in North Carolina school districts and charter schools in 2022-23…

Crime, violence up in NC schools with possession of drugs among highest concern - Vimarsana News

Crime, violence up in NC schools with possession of drugs among highest concern

Schools across the state reported a total of 13,193 acts of crime and violence for the 2022-2023 school year.

Source: yahoo.com
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models - Vimarsana News

Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models

The CanPredict (lung) model was developed, and internally and externally validated, using data from 19·67 million people from two English primary care databases. Our model has potential utility for risk stratification of the UK primary care population and selection of individuals at high risk of lung cancer for targeted screening. If our model is recommended to be implemented in primary care, each individual's risk can be calculated using information in the primary care electronic health records, and people at high risk can be identified for the lung cancer screening programme.